Tevogen Bio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -60 | -59 | -85 | -27 |
EBITDA | -5,602 | -5,458 | -4,521 | -5,373 |
EBIT | -5,662 | -5,517 | -4,606 | -5,664 |
Net Income | -5,761 | -5,446 | -4,677 | -5,726 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,005 | -2,733 | -2,245 | -3,649 |
Cash | 1,082 | 692 | 552 | 1,037 |
Basic Shares | 3,829 | 3,486 | 3,319 | 3,920 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -403 | -378 | ||
EBITDA | -25,570 | -13,139 | -58,892 | 4,639 |
EBIT | -26,079 | -13,543 | -59,271 | 4,408 |
Net Income | -26,275 | -10,114 | -60,477 | 4,408 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,393 | -11,998 | -8,304 | -9,134 |
Cash | 552 | 1,282 | 1,052 | 5,484 |
Basic Shares | 3,319 | 2,933 | 3,308 | 2,400 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.52 |
2026-03-31 | -$1.61 |
2025-12-31 | -$7.96 |
2025-09-30 | -$1.50 |